Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GH Research PLCGHRS · Entity 4545 | Director | September 08, 2026 | September 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GH Research PLC
Report date September 08, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.03 · Expires 2033-09-08 | Direct | 2,303 |
Reported balance
After 2026-09-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 2,303 · Balance 2,303 F1: The share options are immediately fully vested, but are not exercisable until September 8, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: The share options are immediately fully vested, but are not exercisable until September 8, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 9, 2026 20:02 UTC | GH Research PLC GHRS · Entity 4545 | GrantShare Options (Right to Buy) · Derivative | 2,303 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001140361-26-036052 · form4.xml · derivative · entry 1 Schonharting Florian · CIK 0001360509 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,303 Underlying: Ordinary Shares · 2,303 shares Expires 2033-09-08 F1 · derivative.exercise_date: The share options are immediately fully vested, but are not exercisable until September 8, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.